Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
JSS is supported by the Diabetes Research Institute Foundation
Tirzepatida vs
We built this tracker to give patients an easier way to navigate GLP-1 shortages, by: 1 Clearly showing which GLP-1s are currently in shortage by drug and dose 2 Making it easy for everyone to crowdsource where and when they find GLP-1 supply or, when they cannot, to submit a shortage report to the FDA 3 Letting anyone join our Supply List that sends real-time alerts when GLP-1 supply is located at a pharmacy near them 4 Sending automated notifications to patients and providers who sign-up letting them know when a drugs status changes on the FDAs list
While many platforms promise results, few combine the precision of licensed medical guidance with the adaptability of remote care in the way Sprout Health does
While compounded semaglutide was temporarily allowed during drug shortages, it must be phased out by April or May 2025, depending on the facility type
US$ 29.15
.png.jpg)
US$ 29.82
US$ 25.45
US$ 25.16
